Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease.
暂无分享,去创建一个
D. Girelli | O. Olivieri | A. Mazzucco | F. Bernardi | M. Pinotti | F. Manzato | S. Friso | R. Corrocher | P. Ferraresi | C. Russo | Franco Manzato | Alessandro Mazzucco | Francesco Bernardi | F. Manzato | Francesco Bernardi
[1] M. Margaglione,et al. Prothrombotic genetic risk factors in young survivors of myocardial infarction. , 1999, Blood.
[2] A. Hamsten,et al. Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentration. , 1999, Blood.
[3] B. Lämmle,et al. Coagulation factors II, V, VII, and X, prothrombin gene 20210G-->A transition, and factor V Leiden in coronary artery disease: high factor V clotting activity is an independent risk factor for myocardial infarction. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[4] P. Ridker,et al. Assessment of genetic markers for coronary thrombosis: promise and precaution , 1999, The Lancet.
[5] A. Folsom,et al. Correlation of factor VIIa values with factor VII gene polymorphism, fasting and postprandial triglyceride levels, and subclinical carotid atherosclerosis. , 1998, Circulation.
[6] P. Reitsma,et al. A Genetic Propensity to High Factor VII Is not Associated with the Risk of Myocardial Infarction in Men , 1998, Thrombosis and Haemostasis.
[7] E. Trabetti,et al. Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction. , 1998, Blood.
[8] M. Donati,et al. Interpretation of Thrombosis Prevention Trial , 1998, The Lancet.
[9] P. Marckmann,et al. Diet and blood coagulation factor VII—a key protein in arterial thrombosis , 1998, European Journal of Clinical Nutrition.
[10] P. de Knijff,et al. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. , 1998, The New England journal of medicine.
[11] A. Rumley,et al. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[12] A. Arbini,et al. The Arg353Gln polymorphism reduces the level of coagulation factor VII. In vivo and in vitro studies. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[13] H. Prydz,et al. Contribution of factor VII genotype to activated FVII levels. Differences in genotype frequencies between northern and southern European populations. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[14] P. de Knijff,et al. Factor VII polymorphisms in populations with different risks of cardiovascular disease. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[15] A. Folsom,et al. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. , 1997, Circulation.
[16] J. Wang,et al. Polymorphisms of factor V, factor VII, and fibrinogen genes. Relevance to severity of coronary artery disease. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[17] G C Overton,et al. Functional Characterization of the Human Factor VII 5′-Flanking Region (*) , 1996, The Journal of Biological Chemistry.
[18] D. Arveiler,et al. Factor VII Arg/Gln353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study. , 1996, Atherosclerosis.
[19] J. Witte,et al. Genetic dissection of complex traits. , 1994, Nature genetics.
[20] S E Humphries,et al. Genetic determinants of arterial thrombosis. , 1994, Bailliere's best practice & research. Clinical haematology.
[21] P. Comp,et al. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation , 1993 .
[22] V. Fuster,et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.
[23] T. Meade,et al. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[24] S. Rapaport,et al. Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[25] S. Thompson,et al. HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY , 1986, The Lancet.
[26] H. Schulte,et al. Epidemiological Study on Factor VII, Factor VIII and Fibrinogen in an Industrial Population: I. Baseline Data on the Relation to Age, Gender, Body-Weight, Smoking, Alcohol, Pill-Using, and Menopause , 1985, Thrombosis and Haemostasis.
[27] T. Fahey,et al. INTERPRETATION OF THROMBOSIS PREVENTION TRIAL. AUTHORS' REPLY , 1998 .
[28] M. Pinotti,et al. Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[29] G. Assmann,et al. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[30] Kathleen M. Smith,et al. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. , 1989, Proceedings of the National Academy of Sciences of the United States of America.